α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells
Identifieur interne : 001B50 ( Main/Exploration ); précédent : 001B49; suivant : 001B51α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells
Auteurs : K. Ancolio [France] ; C. Alves Da Costa [France] ; K. Uéda [Japon] ; F. Checler [France]Source :
- Neuroscience Letters [ 0304-3940 ] ; 2000.
English descriptors
- KwdEn :
Abstract
Synucleins are neuronal proteins detectable in the neuropathological lesions of several cerebral disorders. Thus, α-synuclein immunoreactivity is found in Lewy bodies, the histopathological hallmark of sporadic Parkinson disease-affected brains. When mutated, α-synuclein seems to be responsible for some familial forms of Parkinson disease. As Lewy bodies are enriched in ubiquitinated structures and also contain proteasome-related immunoreactivity, it could be hypothesized that the proteasome contributes to the cellular degradation of α-synucleins, thereby controlling their concentration-dependent aggregation process. Here, we first demonstrate that α-synuclein is not ubiquitinated in HEK293 cells. Furthermore, by means of two specific inhibitors, we show that wild type and Ala53Thr α-synuclein do not behave as proteasome substrates in HEK293 cells and murine neurons. Our study indicates that the proteasome does not contribute to the control of cellular synucleins concentration and therefore, unlikely participates to cerebral α-synucleinopathies.
Url:
DOI: 10.1016/S0304-3940(00)01049-1
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells</title><author><name sortKey="Ancolio, K" sort="Ancolio, K" uniqKey="Ancolio K" first="K" last="Ancolio">K. Ancolio</name></author><author><name sortKey="Alves Da Costa, C" sort="Alves Da Costa, C" uniqKey="Alves Da Costa C" first="C" last="Alves Da Costa">C. Alves Da Costa</name></author><author><name sortKey="Ueda, K" sort="Ueda, K" uniqKey="Ueda K" first="K" last="Uéda">K. Uéda</name></author><author><name sortKey="Checler, F" sort="Checler, F" uniqKey="Checler F" first="F" last="Checler">F. Checler</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3748DA5E696B3041F875D2CA9DEBA245FE069CF1</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1016/S0304-3940(00)01049-1</idno><idno type="url">https://api.istex.fr/document/3748DA5E696B3041F875D2CA9DEBA245FE069CF1/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">003160</idno><idno type="wicri:Area/Main/Curation">002D61</idno><idno type="wicri:Area/Main/Exploration">001B50</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells</title><author><name sortKey="Ancolio, K" sort="Ancolio, K" uniqKey="Ancolio K" first="K" last="Ancolio">K. Ancolio</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Institut de Pharmacologie Moléculaire et Cellulaire du CNRS, UPR411, 660 Route des Lucioles, Sophia Antipolis, 06560 Valbonne</wicri:regionArea><placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region><settlement type="city">Valbonne</settlement></placeName></affiliation></author><author><name sortKey="Alves Da Costa, C" sort="Alves Da Costa, C" uniqKey="Alves Da Costa C" first="C" last="Alves Da Costa">C. Alves Da Costa</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Institut de Pharmacologie Moléculaire et Cellulaire du CNRS, UPR411, 660 Route des Lucioles, Sophia Antipolis, 06560 Valbonne</wicri:regionArea><placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region><settlement type="city">Valbonne</settlement></placeName></affiliation></author><author><name sortKey="Ueda, K" sort="Ueda, K" uniqKey="Ueda K" first="K" last="Uéda">K. Uéda</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurochemistry, Tokyo Institute of Psychiatry, Setayaga</wicri:regionArea><wicri:noRegion>Setayaga</wicri:noRegion></affiliation></author><author><name sortKey="Checler, F" sort="Checler, F" uniqKey="Checler F" first="F" last="Checler">F. Checler</name><affiliation wicri:level="1"><country wicri:rule="url">France</country></affiliation><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Institut de Pharmacologie Moléculaire et Cellulaire du CNRS, UPR411, 660 Route des Lucioles, Sophia Antipolis, 06560 Valbonne</wicri:regionArea><placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region><settlement type="city">Valbonne</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Neuroscience Letters</title><title level="j" type="abbrev">NSL</title><idno type="ISSN">0304-3940</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000">2000</date><biblScope unit="volume">285</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="79">79</biblScope><biblScope unit="page" to="82">82</biblScope></imprint><idno type="ISSN">0304-3940</idno></series><idno type="istex">3748DA5E696B3041F875D2CA9DEBA245FE069CF1</idno><idno type="DOI">10.1016/S0304-3940(00)01049-1</idno><idno type="PII">S0304-3940(00)01049-1</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0304-3940</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Ala53Thr-α-synuclein</term><term>Alzheimer's disease</term><term>Degradation</term><term>HEK293 cells</term><term>Neurons</term><term>Parkinson disease</term><term>Proteasome</term><term>α-Synuclein</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Synucleins are neuronal proteins detectable in the neuropathological lesions of several cerebral disorders. Thus, α-synuclein immunoreactivity is found in Lewy bodies, the histopathological hallmark of sporadic Parkinson disease-affected brains. When mutated, α-synuclein seems to be responsible for some familial forms of Parkinson disease. As Lewy bodies are enriched in ubiquitinated structures and also contain proteasome-related immunoreactivity, it could be hypothesized that the proteasome contributes to the cellular degradation of α-synucleins, thereby controlling their concentration-dependent aggregation process. Here, we first demonstrate that α-synuclein is not ubiquitinated in HEK293 cells. Furthermore, by means of two specific inhibitors, we show that wild type and Ala53Thr α-synuclein do not behave as proteasome substrates in HEK293 cells and murine neurons. Our study indicates that the proteasome does not contribute to the control of cellular synucleins concentration and therefore, unlikely participates to cerebral α-synucleinopathies.</div></front></TEI><affiliations><list><country><li>France</li><li>Japon</li></country><region><li>Provence-Alpes-Côte d'Azur</li></region><settlement><li>Valbonne</li></settlement></list><tree><country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Ancolio, K" sort="Ancolio, K" uniqKey="Ancolio K" first="K" last="Ancolio">K. Ancolio</name></region><name sortKey="Alves Da Costa, C" sort="Alves Da Costa, C" uniqKey="Alves Da Costa C" first="C" last="Alves Da Costa">C. Alves Da Costa</name><name sortKey="Checler, F" sort="Checler, F" uniqKey="Checler F" first="F" last="Checler">F. Checler</name><name sortKey="Checler, F" sort="Checler, F" uniqKey="Checler F" first="F" last="Checler">F. Checler</name></country><country name="Japon"><noRegion><name sortKey="Ueda, K" sort="Ueda, K" uniqKey="Ueda K" first="K" last="Uéda">K. Uéda</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B50 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B50 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:3748DA5E696B3041F875D2CA9DEBA245FE069CF1
|texte= α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells
}}
| This area was generated with Dilib version V0.6.23. |  |